Immune mediated disease Pt. 1 Flashcards

(43 cards)

1
Q

what is a primary immune mediated disease?

A

Primary (non-associative):
* Defect in immune tolerance
* Antibodies against self

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a secondary immune mediated disease?

A

Secondary (associative):
* Non-self antigens ➔ normal cell membrane
> Antibodies ➔ non-self antigens
* Abnormal immune stimulation
* Possible causes: drugs, inflammatory disorders, infection, neoplasia, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IMHA - what is it, generally? what types are there?

A
  • Destruction of RBCs
  • Primary or secondary IMHA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

IMHA - what type of anemia do we see?

A
  • Regenerative anemia (more common):
    > RBCs in circulation lysed
  • Non-regenerative anemia:
    > RBC precursors at bone marrow level destroyed
    > “Precursor immune mediated anemia” or PIMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Primary IMHA: Signalment

A
  • Anyage,any breed
  • Predisposed:
    > American Cocker spaniels, Bichon, poodles, Old English sheepdogs, collies
    > Most 2-7 years of age
    > Females > males
    > Spring & summer (?)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IMHA: Patient Presentation

A

Clinical signs related to severity of anemia:
* Lethargy, weakness, anorexia
* Collapse
* Tachypnea
* Vomiting, diarrhea
* “Dark” urine (bilirubin, hemoglobinuria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IMHA: Physical Examination common findings

A
  • Pallor (majority of cases)
  • HighHR&RR
  • Enlarged spleen, liver (25-50% of cases), abdominal discomfort
  • Icterus
  • Pigmenturia
  • Hemic murmur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Common mechanisms causing anemia

A
  1. blood loss
  2. lack of production
  3. hemolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

initial tests for dog presenting with anemia

A
  • Complete blood count**
  • Serum biochemical profile
  • Urinalysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

why can we sometimes see Mildly elevated ALT in light of marked anemia

A
  • Hypoxic injury to hepatocytes?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why can we sometimes see elevated bilirubinemia and bilirubinuria in light of marked anemia

A
  • Hemolysis
  • Hypoxic liver injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

IMHA: Diagnosis

A

Anemia
* Hct usually <0.25-0.30 L/L
* (Normal ~0.39-0.50)

Evidence of Ab’s against RBCs:
* + Autoagglutination
* + Coomb’s test
* Spherocytosis (80-90%)

Evidence of hemolysis
* Icterus
* Hemolytic serum/urine

Autoagglutination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is RBC autoagglutination in IMHA? when can we observe it / with what tests?

A
  • May be observed grossly
    > In the tube
  • Slide agglutination test
    > Saline to blood 1:49 ratio
    > 1 drop EDTA blood
    > Check for macro and microscopic agglutination
  • Slide agglutination test not well standardized
    > Some argue it isn’t helpful in the overall case work-up and you’re better off examining the blood smear instead
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the coomb’s test? what does it look for?

A

For IMHA
* Detects Ab or complement on RBC surface
* “Coomb’s reagent”
> Anti-canine IgG, IgM, complement
> Added to washed RBCs
> Detect specific RBC agglutination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Spherocytosis - how does it arise? what does it suggest?

A
  • RBC has antibodies on surface
  • Recognized by macrophages in spleen or liver
    > Phagocytized
    > Partial RBC membrane defect
  • Highly suggestive of IMHA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

IMHA: Extravascular vs Intravascular Hemolysis
- what do we see? what is more common and severe?

A

Extravascular (more common, less severe):
* RBC’s degraded in splenic/hepatic macrophage > Spherocytes
* Hemoglobin released within macrophages
> Processed ➔ bilirubin ➔ icterus

Intravascular:
* RBC’s lysed in circulation
* Hemoglobin released ➔ hemolytic serum, urine

()()()

Both intra and extravascular hemolysis can occur in some IMHA patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How many criteria needed for diagnosis of IMHA? what is ‘suspicious’?

A

“Diagnostic” for IMHA:
* Anemia,
* At least 2 signs of destruction (spherocytes, Coombs, SAT)
* And at least 1 sign of hemolysis (icterus, hemolytic serum, urine)

“Suspicious” for IMHA:
* Anemia
* 1 sign of destruction
* 1 sign hemolysis
* No other causes of anemia identified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How and when to rule out secondary IMHA?

A

Once supportive evidence of IMHA found, consider ruling out secondary causes:
* Client interview to review previous medical history
* Infectious agents – 4Dx snap test, serology depending on area
* Imaging for neoplasia, infections, inflammation
> Thoracic radiographs
> Abdominal ultrasound

19
Q

infectious causes of secondary IMHA

A

Anaplasma
Babesia
Mycoplasma
Heartworm

20
Q

drug causes of secondary IMHA

A

Sulfas
Beta lactams
Certain toxins

21
Q

when can we see direct hemolytic anemia (not immune mediated)

A
  • Zinc ingestion (some pennies, toys, diaper
    cream, dog tags)
  • Hypophosphatemia
  • Onion & garlic
  • Acetaminophen

> check patient history to rule out

22
Q

IMHA: Treatment goals

A
  • Stabilize the patient
  • Stop the immune-mediated destruction
  • Prevent complications
    > Thromboembolism
23
Q

Initial Stabilization strategies for IMHA if we see Signs of dehydration, hemodynamic instability?

A

> IV catheter, start IV fluids

24
Q

“Transfusion triggers” or signs of
insufficient oxygen delivery

A

> Tachycardia, tachypnea, increased work breathing
Dull mental attitude
Very marked anemia

25
Immunosuppressive Medications that can be used for IMHA
- Few studies with high quality evidence to inform clinicians Corticosteroids: * Used alone will result in successful outcome for many patients * No good consensus if/when a second-line immunosuppressive should be added
26
IMHA: Combination Therapy benefits and risks?
Possible benefits: * Improved survival (?) * Better treatment for more severe cases(?) * Ability to wean corticosteroid earlier Risks: * Side effects of medications * Increased risk of secondary infections * Overall lack of evidence
27
Mainstay of IMHA treatment? how fast does it work?
Corticosteroids * Can see improvement within 7 days * Single-agent treatment often sufficient * Common options: * Prednisone @ 2 mg/kg PO q24h * Dexamethasone @ 0.25 mg/kg IV q24h
28
Corticosteroids pros and cons
PROS: * Inexpensive, available * Rapid onset of action * Several mechanisms of impairing the immune system CONS: * PU/PD, polyphagia * Panting * Muscle wasting * Gastric ulceration * Immunosuppression
29
Azathioprine - what does it do?
* Antimetabolite * Inhibits T cell proliferation
30
Azathioprine - potential side effects? when not to use? requires what?
* GI upset * Pancreatitis * Liver toxicity * Bone marrow suppression > Especially cats – do not use * Requires regular monitoring of bloodwork
31
Cyclosporine - what does it do? does it work for IMHA?
* Inhibits T-cell function * Anecdotal efficacy, expensive * Ideal to monitor [drug] levels * Note: different dose / frequency than for skin disease
32
Cyclosporine side effects
* GI upset * Alopecia * Gingival hyperplasia * Opportunistic infections * Neoplasia (?)
33
Mycophenolate - what does it do, what patients is it used in?
* Inhibits T- and B-lymphocyte production * Used in dogs or cats
34
Mycophenolate adverse effects?
* Diarrhea most common
35
Mycophenolate advantages over azathioprine:
* Lack of myelosuppression or hepatotoxicity
36
what % of canine IMHA patients develop thromboembolic complications? pathogenesis?
Up to 80% canine IMHA patients develop thromboembolic complications * Pathogenesis unknown > Activated platelets > Disseminated intravascular coagulation
37
Thromboprophylaxis Options
Platelet inhibition * Clopidogrel * Low dose aspirin (less effective than clopidogrel, typically no longer used alone) Anticoagulants * Heparin * Rivaroxaban Usually just use one of the above options
38
overall example treatment plan for IMHA
* Stabilize the patient > IV Fluid therapy (dehydration / not eating), monitor for transfusion triggers * Immunosuppression > Dexamethasone IV or prednisone PO if taking oral meds * Prevent TE complications > Clopidogrel PO
39
IMHA chronic treatment - how to manage
* Decrease 1 immunosuppressive at a time > Often prednisone first (due to PU/PD, etc) if there are >1 immunosuppressives * Recommend decreasing 1 med by ~25-50%, every 2-4 weeks
40
IMHA: Relapses rate?
* Relapse rate ~15-30%
41
when treating IMHA for the long term, what do we do if Hct has declined compared to last recheck:
* Back to previous doses when Hct was normal * Check Hct frequently (1x/week depending on patient’s condition) * May need to increase back to full immunosuppressive doses * Can try tapering more slowly once normal Hct again * Some need chronic medication for life > Usually low-dose
42
Canine IMHA: Prognosis
* Overall, guarded to poor prognosis for long-term survival * 50% or more mortality rate in some studies > Referral bias? * Majority of deaths/euthanasia within first 2 months > Ongoing disease > Complications
43
Canine IMHA: treatment Summary
* Supportive care (e.g., transfusion, ICU if needed) * Immunosuppression (steroid +/- other agent) * Anti-thrombotics